Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Your provider will determine which medication is best for you based on your health profile and goals
Tirzepatide is a dual GIP/GLP-1 receptor agonist, which may lead to stronger appetite reduction and greater average weight loss for some patients
Medical services are provided by the practice's experienced clinical team, led by Michael Rankin, MD, Board-Certified Internal Medicine, and Kristina Dino, NP, who evaluate each patient and develop individualized treatment plans, including GLP-1 medications when clinically appropriate
The diagnostic criteria for BED requires a person to have at least one binge per week for at least three months, accompanied by marked distress over the behavior
Leave-in treatments extended contact time, often combined with other actives
Similarly, plan meals every 3 to 4 hours to manage hunger and avoid overeating
US$ 21.95
US$ 27.70
US$ 23.03
